Cefotaxime

Cefotaxime Sodium and Sulbactam Sodium is a parenteral combination of a third-generation cephalosporin and a beta-lactamase inhibitor. Cefotaxime inhibits bacterial cell wall synthesis with exceptional activity against Gram-negative bacilli and Streptococcus pneumoniae, while sulbactam neutralizes beta-lactamases produced by resistant pathogens. Indicated for severe intra-abdominal infections, septicemia, meningitis, hospital-acquired pneumonia, and bone and joint infections.

Cefotaxime Sodium and Sulbactam Sodium is a parenteral combination of a third-generation cephalosporin and a beta-lactamase inhibitor. Cefotaxime inhibits bacterial cell wall synthesis with exceptional activity against Gram-negative bacilli and Streptococcus pneumoniae, while sulbactam neutralizes beta-lactamases produced by resistant pathogens. Indicated for severe intra-abdominal infections, septicemia, meningitis, hospital-acquired pneumonia, and bone and joint infections.

Cefotaxime Sodium and Sulbactam Sodium is a parenteral combination of a third-generation cephalosporin and a beta-lactamase inhibitor. Cefotaxime inhibits bacterial cell wall synthesis with exceptional activity against Gram-negative bacilli and Streptococcus pneumoniae, while sulbactam neutralizes beta-lactamases produced by resistant pathogens. Indicated for severe intra-abdominal infections, septicemia, meningitis, hospital-acquired pneumonia, and bone and joint infections.

Cefotaxime Sodium is a third-generation parenteral cephalosporin bactericidal antibiotic. It binds to PBPs to inhibit peptidoglycan synthesis. Features high cerebrospinal fluid (CSF) penetration, making it an essential first-line agent for bacterial meningitis. Also indicated for severe sepsis, bacteremia, peritonitis, complicated urinary tract infections, and lower respiratory infections.

Cefotaxime Sodium is a third-generation parenteral cephalosporin bactericidal antibiotic. It binds to PBPs to inhibit peptidoglycan synthesis. Features high cerebrospinal fluid (CSF) penetration, making it an essential first-line agent for bacterial meningitis. Also indicated for severe sepsis, bacteremia, peritonitis, complicated urinary tract infections, and lower respiratory infections.

Cefotaxime Sodium is a third-generation parenteral cephalosporin bactericidal antibiotic. It binds to PBPs to inhibit peptidoglycan synthesis. Features high cerebrospinal fluid (CSF) penetration, making it an essential first-line agent for bacterial meningitis. Also indicated for severe sepsis, bacteremia, peritonitis, complicated urinary tract infections, and lower respiratory infections.